We deliver the next generation intelligence for insulin pumps, smart pens and other medical devices. Making diabetes care smarter, more reliable and more reassuring than ever before.
Today’s diabetes care is lacking innovation and data¹ shows it’s failing the majority of people living with diabetes in stressful, strenuous or unusual situations. We are in it to change this by bringing next gen technology directly to the people who need it.
bioX® DT models auto-create a Digital Twin of each individual and are trained to predict specific biomarkers, patient reported outcomes (PROs) and health impacting events based on personalized health data streams. It enables users to finally understand their metabolism, the impact of their lifestyle and lets users literally see ahead, which leads to a healthy life. All in real time and open for platforms to plug-in.
bioX® has been built with more than 4.4 Million CGM hours, collected during clinical studies, from in-silico populations and people who donated their everyday data to build a better future together.
bioX® is ultra-lightweight and can be deployed directly to SoCs for maximized system autonomy. Computational intensive tasks can be offloaded to a connected handheld, smartphone or the cloud and update the system periodically or on push.
We provide the complete data infrastructure with MLOps which makes an integration cost-efficient, fast and ready to scale.
Our systems are fully HIPAA compliant; data storage locations can be chosen; bioX® applications can utilize Samsung Knox and iOS hardware-accelerated encryption
Our bioX® technology has been tested extensively over months during in-silico trials, using FDA approved procedures. We leveraged the power of over 100K hours closed-loop application in real life scenario simulations to „battle-test“ the system safety and optimize the performance. A process that would have taken years in traditional, analog R&D cycles.
As a „fresh“ company we are combining state-of-the-art medical research, next gen technology and real life experience. All driven by our passion and ambition to bring innovation to market and people’s lives.
We love talking tech and are happy to dive into the details of our solutions and discuss possible business or research collaborations. Multipliers such as journalists, bloggers, editors are welcome too 🙂
Not a fan of LinkedIn or emails? Drop us a line about your inquiry and we will get back to you.
We’re making bioX® available to everyone. With Newton i/O.
We will never share your email address. Newton ML fully anonymizes data.
+10K
Join more than 10K people on our waitlist.
The founding team has a strong background in technology, medicine and digital products. Our developers come from fin-tech, FAANG and are experts in their fields.
We are proud and happy to be already supported by dynamic and acknowledged advisors.
We believe in lightweight structures, fast development cycles and the power of the right partners and advisors.
We know where our strengths lie and therefore work closely with ISO and QMS certified partners.
© Copyright 2024 OneTwenty AG, All rights reserved.
¹ PMID: 19254969; https://doi.org/10.1155/2020/1834534; https://doi.org/10.1007/s00125-021-05396-5; PMID: 26649106; PMID: 34790639
² https://doi.org/10.1002/edm2.379; https://doi.org/10.2337/dci21-0043; 12 week measurements compared to study baselines
³ Reported time <50mg/dL across all subjects over 12 weeks: average of 0.78% and median of 0.21% time spent in hypoglycemia
⁴ ML prediction up to a 120 minute horizon and accuracy per point measurement at 76.8% ±4.2%
bioX is an investigational solution limited by Swiss law to investigational use. Not available for sale. To be clear, bioX is not yet commercially available because it has not yet been cleared by the MDR or FDA or any other regulatory body. We will have to obtain regulatory clearances before we can offer it for commercial sale.
OneTwenty and bioX are registered trademarks of OneTwenty AG. Other trademarks are the property of their respective owners. No use of any OneTwenty AG trademark, trade name, or trade dress in this site may be made without the prior written authorisation of OneTwenty AG, except to identify the product or services of the company. The product images are for illustrative purposes only.